Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center

BJ O'Hea, AM El-Shirbiny, SDJ Yeh, PP Rosen… - Journal of the American …, 1998 - Elsevier
Background: Sentinel node biopsy (SNB) has emerged as a potential alternative to routine
axillary dissection in clinically node-negative breast cancer. Study Design: From September …

Prostatic specific antigen

AM El-Shirbiny - Advances in clinical chemistry, 1994 - Elsevier
In recent years prostatic specific antigen (PSA) has emerged as the most important tumor
marker for prostate cancer. Prostate cancer is the most commonly diagnosed malignancy in …

[PDF][PDF] Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma

AM El-Shirbiny, H Yeung, M Imbriaco… - Journal of Nuclear …, 1997 - Soc Nuclear Med
DISCUSSION Mulliple myeloma is characlerized by malignanl proliferalion of clonal plasma
cells and excessive formation of nonoclonal immunoglobulin. Deteclion of bone lesions in …

Single chain antigen binding protein (sFv CC49) First human studies in colorectal carcinoma metastatic to liver

SM Larson, AM ElShirbiny, CR Divgi… - … Journal of the …, 1997 - Wiley Online Library
BACKGROUND An sFv fragment of the anti‐TAG‐72 monoclonal antibody CC49 has been
developed and has shown promise in improved targeting to colorectal carcinoma in animal …

[PDF][PDF] Jod-Basedow syndrome following oral iodine and radioiodinated-antibody administration

AM El-Shirbiny, SS Stavrou, A Dnistrian… - Journal of Nuclear …, 1997 - Soc Nuclear Med
This is a case of thyrotoxicosis, presumably due to Jod-Basedow syndrome, after stable
iodine ingestion for thyroid blockade in a patient with ovarian carcinoma having 1311-…

Serum prostate-specific antige: hourly change/24 hours compared with prostatic acid phosphatase

AMF El-Shirbiny, T Nilson - Urology, 1990 - Elsevier
Simutaneous hourly changes in serum PSA and PAP levels per twenty four-hour period was
studied in 19 urologic patients with no prostatic disease. Serum PSA was determined using …

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.

…, R Pettengall, M Imbriaco, A El-Shirbiny… - Clinical cancer research …, 1998 - AACR
To assess the tumor targeting, safety, and efficacy of monoclonal antibody 131I-labeled CC49
in patients with androgen-independent prostate cancer, 16 patients received 75 mCi/m2 of …

Diurnal variation of prostatic acid phosphatase (PAP) in urologic patients with nonprostatic disease

AMF El-Shirbiny, HN Pawar, TEG Nilson - Urology, 1986 - Elsevier
Variation in serum prostatic acid phosphatase (PAP) level over a twenty-four-hour period
was studied in 18 urologic patients with no prostatic disease. Hourly, twenty-four-hour serum …

Enzyme immunoassay of prostatic acid phosphatase after prostatic examination: Correlation with prostate size and immunopathology

AMF El-Shirbiny, P Shridhar, MS Al Adnani, LK Suresh - Urology, 1988 - Elsevier
Variation in serum prostatic acid phosphatase (PAP) after prostatic digital examination was
studied in 22 patients, 18 with benign prostatic hyperplasia (BPH), and 4 with prostatic …

Comparision of immunologic and enzymatic assay of prostatic acid phosphatase for follow‐up and assessment of clinical status of stage d prostate cancer

A ElShirbiny, A Bhargava, S Beckley… - Journal of Surgical …, 1984 - Wiley Online Library
… The buffer in the cell was 0.5 M sodium phosphate pH 6.5. A constant current of 8 mamp/ inch
was applied for 2 hours at 4C. The plates were then stained with 0.1 % of … El-Shirbiny et a1 …